Eculizumab improves fatigue in refractory generalized myasthenia gravis

PURPOSE: To evaluate the effect of eculizumab on perceived fatigue in patients with anti-acetylcholine receptor antibody-positive, refractory, generalized myasthenia gravis (MG) using the Quality of Life in Neurological Disorders (Neuro-QOL) Fatigue subscale, and to evaluate correlations between imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersen, Henning, Mantegazza, Renato, Wang, Jing Jing, O’Brien, Fanny, Patra, Kaushik, Howard, James F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620379/
https://www.ncbi.nlm.nih.gov/pubmed/30905021
http://dx.doi.org/10.1007/s11136-019-02148-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620379/
https://www.ncbi.nlm.nih.gov/pubmed/30905021
http://dx.doi.org/10.1007/s11136-019-02148-2

Ejemplares similares